Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load

Vox Sanguinis

Volumn 92, Issue 1, 2007, Pages 8-14

  Katsoulidou, A ^a   Moschidis, Z ^a   Sypsa, V ^a   Chini, M ^b   Papatheodoridis, G V ^a   Tassopoulos, N C ^c   Mimidis, K ^d   Karafoulidou, A ^e   Hatzakis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d Surgery Gen Hospital Alexandroupolis   (Greece)

^e LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Blood screening; HBV DNA; HCV RNA; HIV 1 RNA; Nucleic acid testing; Transcription mediated amplification

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; VIRUS RNA;

ANALYTIC METHOD; ARTICLE; BLOOD DONOR; CONFIDENCE INTERVAL; DIAGNOSTIC TEST; DISCRIMINANT ANALYSIS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICS; VIRUS LOAD;

BLOOD DONORS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIRAL LOAD;

EID: 33845666218     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00857.x     Document Type: Article

References (29)

1. Hewlett IK, Epstein JS: Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening. Transfusion 1997; 37:346-351
2. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP 4th, Petersen LR: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333:1721-1725
3. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Lelie PN: Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report. Vox Sang 1995; 68:55-56
4. Assal A, Coste J, Barlet V, Laperche S, Cornillot C, Smilovici W, Pillonel J, Andreu G: Application of molecular biology to blood transfusion safety: the nucleic acid testing. Transfus Clin Biol 2003; 10:217-226
5. Katsoulidou AS, Moschidis ZM, Gialeraki RE, Paraskevis DN, Sypsa VA, Lazanas MC, Tassopoulos NC, Psichogiou MA, Boletis JN, Karafoulidou AS, Hatzakis AE: Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion. Transfusion 2004; 44:59-66
6. Jackson JB, Smith K, Knott C, Korpela A, Simmons A, Piwowar-Manning E, McDonough S, Mimms L, Vargo JM: Sensitivity of the Procleix HIV-1/HCV assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA in a high-risk population. J Clin Microbiol 2002; 40:2387-2391
7. Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH: Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2002; 40:2408-2419
8. Paraskevis D, Haida C, Tassopoulos N, Raptopoulou M, Tsantoulas D, Papachristou H, Sypsa V, Hatzakis A: Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods 2002; 103:201-212
9. Finney DJ: Probit Analysis: Parallel Line Analysis. Cambridge, Cambridge University Press, 1971.
10. Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT: Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005; 45:1258-1266
11. Lelie PN, van Drimmelen HA, Cuypers HT, Best SJ, Stramer SL, Hyland C, Allain JP, Moncharmont P, Defer C, Nubling M, Glauser A, da Silva Cardoso M, Viret JF, Lankinen MH, Grillner L, Wirthmuller U, Coste J, Schottstedt V, Masecar B, Dax EM: Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion 2002; 42:527-536
12. US Food and Drug Administration: Guidance for Industry: In the Manufacture and Clinical Evaluation of in vitro Tests to Detect Nucleic acid Sequences of Human Immunodeficiency Viruses Types 1 and 2 [Internet]. 64 FR 71147. Rockville, MD, U.S. Food and Drug Administration, 1999. Available from http://www.fda.gov/OHRMS/DOCKETS/98fr/cb9939.pdf
13. Draft guidance for industry: use of nucleic acid tests on pooled and individual samples from donors of whole blood and blood components for transfusion to adequately and appropriately reduce the risk of transmission of HIV-1 and HCV [Internet] Rockville (MD): US Food and Drug Administration; 2002 Mar. Available from: http://www.fda.gov/OHRMS/DOCKETS/98fr/02d-0096-gd/001_vol1. pdf
14. Ferreira MC, Nel TJ: Differential transmission of human immunodeficiency virus (HIV) via blood components from an HIV-infected donor. Transfusion 2006; 46:156-157
15. Salomao R, Oliveira JS, Oliveira CF, Diaz RS, Minelli H, Valdetaro F: Passive transfer of HIV-1 antibodies and absence of HIV infection after the transfusion of HIV-1-seropositive red cells. Transfusion 2000; 40:252-253
16. Katayama K, Kumagai J, Komiya Y, Mizui M, Yugi H, Kishimoto S, Yamanaka R, Tamatsukuri S, Tomoguri T, Miyakawa Y, Tanaka J, Yoshizawa H: Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology 2004; 47:57-64
17. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H: Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993; 67:1953-1958
18. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, Shih JW, Neuwald PD: Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 1995; 2:121-132
19. McAuley JD, Caglioti S, Williams RC, Robertson GF, Morgan L, Tobler LH, Busch MP: Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay. Transfusion 2004; 44:91-96
20. Lelie NHA: Hepatitis B - A review of the role of NAT in enhancing blood safety. J Clin Virol 2006; 36:S1
21. Ling AE, Robbins KE, Brown TM, Dunmire V, Thoe SY, Wong SY, Leo YS, Teo D, Gallarda J, Phelps B, Chamberland ME, Busch MP, Folks TM, Kalish ML: Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 2000; 284:210-214
22. Candotti D, Richetin A, Cant B, Temple J, Sims C, Reeves I, Barbara JA, Allain JP: Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion 2003; 43:215-225
23. Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S: Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000; 355:41-42
24. Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H: Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001; 41:1107-1113
25. Kleinman SH, Busch MP: HBV: amplified and back in the blood safety spotlight. Transfusion 2001; 41:1081-1085
26. Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Nojiri N, Juji T, Hoshino H, Shimoda K, Hino K, Kimura S, Iino S, Koike K: Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001; 41:1093-1099
27. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP: Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43:696-704
28. Prince AM, Lee DH, Brotman B: Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion 2001; 41:329-332
29. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS: Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002; 42:1592-1597